A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
Public ClinicalTrials.gov record NCT00088621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Twelve-Month Study of Safety and Tolerability in the Treatment of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia
Study identification
- NCT ID
- NCT00088621
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2004
- Primary completion
- Sep 30, 2005
- Completion
- Sep 30, 2005
- Last update posted
- Apr 16, 2014
2004 – 2005
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Psychiatry Pharmaceutical | Birmingham | Alabama | 35209 | — |
| Summit Research Group | Little Rock | Arkansas | 72211 | — |
| Comprehensive NeuroScience | Cerritos | California | 90703 | — |
| Collaborative Neuro Science Network, Inc. | Garden Grove | California | 92845 | — |
| Optimum Health Services | La Mesa | California | 91942 | — |
| California Clinical Trials | San Diego | California | 92123 | — |
| CA Neutopsychopharmacology Clinical Research Institute (CNRI) | San Diego | California | 92126 | — |
| Pacific Clinical Research | Upland | California | 91786 | — |
| Comprehensive NeuroScience, Inc | Washington D.C. | District of Columbia | 20016 | — |
| Segal Institute for Clinical Research | Fort Lauderdale | Florida | 33301 | — |
| Segal Institute for Clinical Research | North Miami | Florida | 33161 | — |
| University of South Florida, Department of Psychiatry and Behavioral Medicine | Tampa | Florida | 33613 | — |
| Comprehensive Neuroscience, Inc. | Hoffman Estates | Illinois | 60194 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| CNS Research Institute | Clementon | New Jersey | 08021 | — |
| Quantum Clinical Services Group | Philadelphia | Pennsylvania | 19139 | — |
| Community Clinical Research | Austin | Texas | 78729 | — |
| Future Search Trials | Austin | Texas | 78756 | — |
| Claghorn Lesem Research Clinic, Inc. | Bellaire | Texas | 77401 | — |
| InSite Clinical Research | DeSoto | Texas | 75115 | — |
| CBH Health, L.L.C - Dominion Hospital | Falls Church | Virginia | 22044 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00088621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2014 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00088621 live on ClinicalTrials.gov.